Atlas Trials

First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation

Clinical trial NCT07536724 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07536724
Sponsor
Medira GmbH
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Symptomatic Tricuspid Regurgitation (TR) Graded as Severe or Greater
Start date
2026-05-01
Primary completion
2027-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.